Open AccessRole of Zoledronate in Aromatase Activity Should Be Considered in Future Studies
Author(s) -
Ghobadifar Mohamed Amin
Publication year - 2013
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2013-0208
Subject(s) - aromatase , medicine , breast cancer , estrogen , oncology , anastrozole , zoledronic acid , aromatase inhibitor , pharmacology , cancer research , bioinformatics , cancer , biology
Considering the additive effect of zoledronate on aromatase activity, plasma estrogen levels should be investigated or controlled for in future trials that seek to elucidate the mechanisms and components responsible for the recently reported effects of zoledronate in women with breast cancer.